Cynthia Smith Dicerna Pharmaceuticals Inc (DRNA) insider trading activity
Cynthia Smith is Director of Dicerna Pharmaceuticals Inc. Currently has a direct ownership of 0 shares of DRNA, which is worth approximately $0. The most recent transaction as insider was on Dec 28, 2021, when has been sold 3,333 shares (Common Stock) at a price of $38.25 per share, resulting in proceeds of $127,487. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
Cynthia Smith Transaction History
Also insider at
CS
Cynthia Smith
Director
Cambridge, MA